CDC Distributing Monkeypox Vaccines Nationwide While Raising Monkeypox Travel Alert to Level 2

CDC Distributing Monkeypox Vaccines Nationwide While Raising Monkeypox Travel Alert to Level 2

On June 6, 2022, the U.S. Centers for Disease Control and Prevention (CDC) raised its monkeypox travel alert to Level 2, warning Americans to “Practice Enhanced Precautions.”1 The agency stated that monkeypox cases have been rising in at least 29 countries, with 1,019 infections reported to date. Currently, the United States has confirmed 31 cases […]

Smallpox Vaccine Manufacturers See Big Stock Price Increases After Monkeypox Outbreaks Reported

Smallpox Vaccine Manufacturers See Big Stock Price Increases After Monkeypox Outbreaks Reported

On May 26, 2022, U.S. Centers for Disease Control (CDC) officials held a press briefing and announced there had been nine cases of monkeypox identified in seven U.S. states and that two licensed smallpox vaccines were in the national stockpile and ready to be distributed.1 The CDC’s director said, “The U.S. has the resources we […]

Monkeypox Cases in U.S. Coincide With Vaccine Purchases by BARDA

Monkeypox Cases in U.S. Coincide With Vaccine Purchases by BARDA

The World Health Organization (WHO) announced on May 21, 2022 that more than 100 confirmed or suspected cases of monkeypox had been identified in 12 countries, including between one and five confirmed cases in the U.S.1 Most of the cases have occurred in Europe with higher numbers in Portugal, Spain and the U.K.  WHO officials […]

Vaccine Market Valued at $93 Billion by 2026

Vaccine Market Valued at $93 Billion by 2026

A recent report by Fortune Business Insights projects the value of the world market for vaccines to reach $93.08 billion by 2026, with a Compound Annual Growth Rate (CAGR) of 10.7 percent during the forecast period.1 One of the main drivers of the vaccine market is the need for greater supplies of vaccines, given stricter government […]